Noventure and Laboratorios Salvat enter into agreement to commercialise innovative medical device in Spain and Portugal for rhinitis and rhinosinusitis
The Vygon Group welcomes Anne Najaint as CFO
Robocath sets up medical advisory board composed of international interventional cardiology key leaders
SafeHeal starts first-in-human and CE-mark clinical study of endoluminal bypass sheath with the potential of replacing ostomy
Sebia announces FDA clearance for its Hydrashift 2/4 daratumumab assay
Discngine raises €1.1 million ($1.3M) in Series A funding round
Robocath raises a total of €6.4 million in 2017
Cardiabase, a Banook Group company, supports the WHO in the fight against malaria
